Purdue Pharma nabs court approval for $397M sale of consumer health unit

A federal bankruptcy judge on Tuesday approved Purdue Pharma’s $397 million sale of its consumer health unit to a subsidiary of Arcadia Consumer Healthcare. The news comes as Purdue awaits the court’s approval of a proposed settlement worth more than $10 billion to resolve civil claims over its role in…

Click to view original post